Left ventricular hypertrophy in chronic kidney disease: A diagnostic criteria comparison

Emilio Nardi1, Giuseppe Mulè1, Antonina Giammanco1

  • 1Dipartimento di Promozione Della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza "G. D'Alessandro" (PROMISE), Università Degli Studi di Palermo, Italy.

Insights

Left ventricular hypertrophy (LVH) is common in chronic kidney disease (CKD) patients, increasing cardiovascular risk. This study found LVH and impaired diastolic function are prevalent in CKD patients, particularly in advanced stages.

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension

Background:

  • Chronic kidney disease (CKD) is associated with increased cardiovascular risk.
  • Left ventricular hypertrophy (LVH) is a common complication in CKD patients.
  • Understanding LVH prevalence and geometry in CKD is crucial for risk stratification.

Purpose of the Study:

  • To determine the prevalence of LVH and left ventricular geometry in hypertensive patients with stage 2-5 CKD.
  • To compare LVH and geometry in CKD patients versus essential hypertensive patients with normal renal function.
  • To investigate the impact of CKD on diastolic function.

Main Methods:

  • Echocardiographic examination of 293 hypertensive patients with stage 2-5 CKD and 289 essential hypertensive patients.
  • Exclusion of patients with stage 1 CKD, dialysis, or pre-existing cardiovascular diseases.
  • Statistical analysis including multiple regression to assess the association between renal function and LVH.

Main Results:

  • LVH was significantly more prevalent in CKD patients (62.8%) compared to essential hypertensives (51.9%).
  • Advanced CKD stages showed increased left ventricular dimensions, thickness, and mass.
  • Diastolic function was notably worse in CKD patients, especially in later stages.

Conclusions:

  • LVH is highly prevalent in CKD patients, often presenting with increased wall thickness and diameter.
  • CKD-associated LVH negatively impacts diastolic function.
  • Early detection and management of LVH in CKD are essential to mitigate cardiovascular risk.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
227
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
456
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
181
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
384
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
393
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.4K